KEGG   DRUG: Migaldendranib
Entry
D13058                      Drug                                   
Name
Migaldendranib (USAN/INN)
Formula
C853H1464F7N235O237
Exact mass
18925.9618
Mol weight
18937.17
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
Efficacy
Angiogenesis inhibitor (ophtalmologic), Receptor tyrosine kinase inhibitor
Comment
Treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME)
Dendrimer
Target
VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
VEGFR2 (KDR) [HSA:3791] [KO:K05098]
PDGFRA [HSA:5156] [KO:K04363]
PDGFRB [HSA:5159] [KO:K05089]
CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
KIT (CD117) [HSA:3815] [KO:K05091]
  Pathway
hsa04010  MAPK signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa04370  VEGF signaling pathway
hsa04640  Hematopoietic cell lineage
Interaction
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    D13058  Migaldendranib
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   PDGFR family
    PDGFRA
     D13058  Migaldendranib (USAN/INN)
    PDGFRB
     D13058  Migaldendranib (USAN/INN)
    KIT (CD117)
     D13058  Migaldendranib (USAN/INN)
   VEGFR family
    VEGFR1 (FLT1)
     D13058  Migaldendranib (USAN/INN)
    VEGFR2 (KDR)
     D13058  Migaldendranib (USAN/INN)
 Signaling molecules and receptors
  Cytokine receptors
   CSF and other factor receptors
    CSF1R (FMS, CD115)
     D13058  Migaldendranib (USAN/INN)
Other DBs
CAS: 2757474-53-4
PubChem: 505917331
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system